CVS Health (CVS) stock is lower in Tuesday's session on news the pharmacy chain's board of directors is conducting a strategic review of its business, according to media reports. Track all markets ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Humidifiers can help introduce more moisture into your home by emitting water vapor into the air, which helps alleviate dry skin, chapped lips, nosebleeds and other dry-weather conditions.

It’s time for a wellness check at CVS Health. Shares of the company are down more than 20% this year as it grapples with higher-than-expected medical costs in its insurance unit and pharmacy ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

CVS Health ( NYSE:CVS ) Third Quarter 2024 Results Key Financial Results Revenue: US$95.4b (up 6.6% from 3Q 2023). Net... CVS Health Corp (CVS) reports robust growth in retail pharmacy and health ...

The most recent trading session ended with CVS Health (CVS) standing at $66.85, reflecting a +1.33% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered ...

CVS Health is planning to cut about 2,900 jobs in an effort to slash costs, the US health care company said Tuesday. “We’ve embarked on a multi-year initiative to deliver $2 billion in cost ...

CVS Health (NYSE: CVS, $67.46, Market Capitalization: $84.86 billion), a leading health solutions company in the US, is considering a potential break-up to separate its retail and insurance units.

CVS Health has replaced Karen Lynch with David Joyner as CEO, it said Friday, part of an attempt to turn the struggling company around. Joyner was previously the president of CVS Caremark, ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David Joyner replacing Karen Lynch. CVS also withdrew its 2024 profit ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...